Eton Pharmaceuticals Inc. (ETON) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Eton Pharmaceuticals Inc.

NASDAQ: ETON · Real-Time Price · USD
19.93
0.13 (0.66%)
At close: Oct 03, 2025, 3:59 PM
19.80
-0.65%
After-hours: Oct 03, 2025, 07:11 PM EDT

Eton Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
14.94M 21.39M 16.3M 14.41M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
12K 12K 12K 21K
Receivables
5.36M 3.41M 1.85M 5.47M
Inventory
15.23M 911K 557K 550K
Other Current Assets
5.49M n/a n/a n/a
Total Current Assets
41.02M 26.84M 20M 23.6M
Property-Plant & Equipment
209K 150K 260K 219K
Goodwill & Intangibles
34.88M 4.74M 4.75M 3.62M
Total Long-Term Assets
35.1M 4.9M 5.03M 3.86M
Total Assets
76.12M 31.74M 25.03M 27.46M
Account Payables
4.17M 1.85M 1.77M 1.77M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 5.38M 1.03M 1.42M
Other Current Liabilities
15.74M n/a n/a n/a
Total Current Liabilities
19.95M 16.24M 6.46M 4.56M
Long-Term Debt
29.81M n/a 5.38M 5.26M
Other Long-Term Liabilities
1.83M n/a n/a n/a
Total Long-Term Liabilities
31.75M 22K 5.49M 5.28M
Total Liabilities
51.7M 16.26M 11.95M 9.84M
Total Debt
29.92M 5.4M 6.52M 6.7M
Book Value
24.43M 15.48M 13.08M 17.63M
Book Value Per Share
0.94 0.60 0.52 0.70
Common Stock
27K 26K 25K 25K
Retained Earnings
-107.89M -104.07M -103.13M -94.11M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
24.43M 15.48M 13.08M 17.63M
Total Investments
n/a n/a n/a n/a